Menu
Recruiting NCT03732131

The Finnish Faecal Microbiota Transplantation Study (FINFMT)

— Observational Faecal Microbiota Transplantation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Faecal Microbiota Transplantation. Basic parameters: 18 years — 120 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Finland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Long Term Safety and Efficacy of Faecal Microbiota Transplantation: a Nationwide Obeservational Study

Overview

The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.

Primary outcome measures

  • The long term effects of FMT -questionnaire [Time frame: 10 years]

Eligibility criteria

Inclusion criteria

  • > 18 years age
  • receiving FMT for rCDI or any other madical condition
  • written consent
  • Not included in other FMT trials

Exclusion criteria

  • Unable to provide written consent
  • < 18 years age
  • Included in other FMT-trial

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Finland · 1 center
  • Joint Authority for Päijät-Häme Social and Health Care — Lahti

Identifiers

NCT: NCT03732131 · HUS/3198/2017

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗